Posted on 10/21/20
MTX Group Launches Vaccine Management and Inventory Solution for Public Health Departments
MTX provides customized vaccine management solutions, including recently deploying the first cloud-based Vaccine Management Solution in the country with the City of Chicago. MTX Group, a . . .
Posted on 10/20/20
Lantern Hill Offers Excellent Health Care on Campus
Residents have easy access to the very best health and wellness services.Lantern Hill’s on-site medical center staff provide televisits as well as in-person, in-home, and phone . . .
Posted on 10/20/20
IQVIA Reports Third-Quarter 2020 Results
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to . . .
Posted on 10/29/20
Interview with Kevin Hrusovsky, Chairman & CEO, Quanterix
Spend a few minutes with Kevin Hrusovsky, President, CEO and Chairman of Quanterix, and you will quickly
Posted on 10/19/20
Phreesia Proposes Public Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR), a leading patient intake management platform, announced today that it has commenced an underwritten public offering of 5,000,000 shares of its . . .
Posted on 10/19/20
Why I Think Bristol Myers Squibb Is Too Cheap to Miss
For investors in pharmaceutical companies, few things are more concerning than a loss of market share, particularly if it's because of the patent expiration of a . . .
Posted on 10/19/20
Better Buy: Amgen vs. Bristol Myers Squibb
Amgen (NASDAQ:AMGN) and Bristol Myers Squibb (NYSE:BMY) share quite a few things in common. Both, of course, are big drugmakers with several successful products on the . . .
Posted on 10/19/20
Teladoc Health & Livongo Merger-Explained
It's a no brainer that healthcare is shifting away from "fee for service" and more toward "value-based care". As this shift continues, innovative companies focusing on . . .
Posted on 10/16/20
Johnson & Johnson: Great Company To Buy And Hold
SummaryJohnson & Johnson's stock dropped somewhat after its earnings announcement. The company beat analysts' estimates but the market reacted to the bad Covid-19 vaccine news.I do . . .
Posted on 10/16/20
Royalty Pharma Prices of Class A Ordinary Shares
NEW YORK, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today the pricing of the secondary offering of 17,343,037 shares of its Class . . .
Posted on 10/15/20
BrainStorm Announces Financial Results for the Third Quarter 2020
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial results for the third quarter ended September 30, . . .
Posted on 10/15/20
Johnson & Johnson Curiously Valued In A Still-Healthy Med-Tech Sector
Summary Johnson & Johnson beat expectations by a comfortable margin in Q3'20, driven by the device business, but investors seem concerned about the risk that the . . .
Posted on 10/15/20
Better Buy: AbbVie vs. Johnson & Johnson
Many large pharmaceutical companies fall into the category of widow-and-orphan stocks -- stocks that have a relatively high dividend yield and pose very low risks to . . .
Posted on 10/14/20
Goldfinch Bio Honored by Goldman Sachs for Entrepreneurship
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced that Goldman . . .
Posted on 10/14/20
Altruista Health Partners with Healthify
Healthify’s social determinants of health (SDoH) infrastructure will be integrated in Altruista’s GuidingCare® platform to support health plans in addressing social needs of members Healthify, a . . .
Posted on 10/14/20
Conversion Labs Reverse Splits Common Shares
NEW YORK, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, will effect a 1-for-5 reverse split of . . .
Posted on 10/14/20
Johnson & Johnson: Still No Reason To Own
SummaryJNJ easily beat reduced Q3 earnings estimates.The healthcare company guided up for 2020, but the new estimates are still down $1 from original targets.The stock continues . . .
Posted on 10/14/20
Royalty Pharma Offers Secondary of Class A Ordinary Shares
NEW YORK, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today that certain selling shareholders intend to offer an aggregate 17,343,037 of the . . .
Posted on 10/13/20
Johnson & Johnson Reports 2020 Third-Quarter Results
Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2020. "Our third-quarter results reflect solid performance and positive trends across Johnson & Johnson, powered by . . .
Posted on 10/13/20
3 Reasons Pfizer and BioNTech Will Have Coronavirus Vaccine Data Before Moderna
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) started the phase 3 clinical trial for their coronavirus vaccine BNT162b2 around the same time as Moderna (NASDAQ:MRNA) started its phase . . .
Posted on 10/13/20
Pfizer Reports Data, And Other News: The Good, Bad And Ugly Of Biopharma
SummaryPfizer reports encouraging results for growth hormone deficiency trial.Dexcom collaborates with Lilly for diabetes management program.Exelixis and Aurigene reports positive data for cancer treatment AUR102.Looking for . . .
Posted on 10/13/20
Pfizer and BioNTech Coronavirus Vaccine Accepted for Rolling Review in Canada
The coronavirus vaccine candidate being developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) is now undergoing its first regulatory review in North America. The two companies announced . . .
Posted on 10/13/20
Report: Johnson & Johnson Coronavirus Vaccine Study Paused Due To Participant's Unexplained Illness
The clinical trial of Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine candidate has been paused due to an unexplained illness in a study participant, according to an . . .
Posted on 10/13/20
Sickle Cell Disease Association of America and Aruvant Sciences Forge New Partnership
The Sickle Cell Disease Association of America (SCDAA) and Aruvant Sciences are proud to announce a new partnership to create educational programs to increase awareness of . . .
Posted on 10/12/20
Dr. Manish Parikh Appointed Chief of Cardiology at NewYork-Presbyterian Brooklyn Methodist Hospital
Dr. Manish A. Parikh, an internationally renowned clinical interventional cardiologist and educator, has been named chief of cardiology at NewYork-Presbyterian Brooklyn Methodist Hospital. He also returns . . .
New York
